相关实验视频
Updated: Jul 9, 2026

10:58
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
在开发新型蛋白质催化剂时,协同设计辅因子和活性位结构
Takafumi Ueno1, Tomomi Koshiyama, Masataka Ohashi
1Research Center for Materials Science and Department of Chemistry, Graduate School of Science, Nagoya University, Nagoya 464-8602, Japan.
Journal of the American Chemical Society
|May 5, 2005
概括
研究人员通过确定Apo-myoglobin内的金属复合物的晶体结构来开发出新的人工金属酶. 这一突破允许通过活性部位设计精确控制生物催化反应中的酶选择性.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 催化剂是一种催化剂.
背景情况:
- 人工金属酶对于新型生物催化剂和生物材料至关重要.
- 之前的合成方法缺乏结构信息,阻碍了反应性改进.
研究的目的:
- 为了确定M(III) ((Schiff基) 的晶体结构.apo-A71GMbs (M = Cr和Mn).
- 了解金属复合物在阿波-肌球蛋白 (apo-Mb) 中的定位如何影响反应性.
- 通过活性位点工程来控制酶反应中的酶选择性.
主要方法:
- 结晶学以确定M(III) 的结构.apo-A71GMbs.
- 在apo-Mb活性位点内的非共价相互作用和金属离子结合的分析.
- 修改希夫基联体替代剂以控制反选择性.
主要成果:
- 晶体结构揭示了金属复合物定位,其定位受相互作用和丁结合的调节.
- 在Ile107和配体替代剂之间的特定相互作用决定了希夫基配体的位置.
- 通过改变连接物替代剂,成功控制了安醇硫化中的酶选择性.
结论:
- 蛋白质活性部位的设计,特别是金属复合体的修饰,可以精确地控制酶的酶选择活性.
- 这项研究提供了第一个由蛋白质活性部位内的设计金属复合体调节的酶选择性酶反应的例子.
相关概念视频
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Protein Complexes with Interchangeable Parts
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Introduction to Mechanisms of Enzyme Catalysis
For many years, scientists thought that enzyme-substrate binding took place in a simple "lock-and-key" fashion. This model stated that the enzyme and substrate fit together perfectly in one instantaneous step. However, current research supports a more refined view scientists call induced fit. The induced-fit model expands upon the lock-and-key model by describing a more dynamic interaction between enzyme and substrate. As the enzyme and substrate come together, their interaction causes a mild...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Bacterial Protein Maturation
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...

